Literature DB >> 19013498

Impact of a constitutively active luteinizing hormone receptor on testicular gene expression and postnatal Leydig cell development.

Mary M Coonce1, Amanda C Rabideau, Stacey McGee, Keriayn Smith, Prema Narayan.   

Abstract

The actions of luteinizing hormone (LH) mediated through its receptor (LHR) are critical for testicular steroidogenesis and Leydig cell differentiation. We have previously characterized transgenic mice expressing a genetically engineered, constitutively active yoked hormone-receptor complex (YHR), in which a fusion protein of human chorionic gonadotropin (hCG) was covalently linked to LHR. Elevated testosterone levels were detected in male mice expressing YHR (YHR(+)) at 3 and 5 weeks of age, accompanied by decreases in testicular weight and serum levels of LH and follicle stimulating hormone (FSH). Here we report a temporal study to identify testicular genes whose expression is altered in YHR(+) mice during postnatal development. The mRNA expression levels for the steroidogenic enzymes, P450 17alpha-hydroxylase, 17beta-hydroxysteroid dehydrogenase3 and 5alpha-reductase1 were down-regulated in 3- and 5-week-old YHR(+) testis. This result coupled with an immunohistochemical analysis of Leydig cell specific proteins and quantification of Leydig cell numbers identified a decrease in adult Leydig cells in YHR(+) mice. Surprisingly, no change was detected for cytochrome P450 side-chain cleavage or steroidogenic acute regulatory protein RNA levels between WT and YHR(+) mice. In contrast, mRNA levels for insulin-like growth factor binding protein 3 were up-regulated in 3- and 5-week-old YHR(+) mice. The mRNA levels for several germ cell-specific proteins were up-regulated at 5 weeks of age in both WT and YHR(+) mice. We conclude that premature high levels of testosterone alter the expression of a select number of testicular genes and impair the differentiation of adult Leydig cells in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013498      PMCID: PMC2653066          DOI: 10.1016/j.mce.2008.10.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  44 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Origin, differentiation and regulation of fetal and adult Leydig cells.

Authors:  R Habert; H Lejeune; J M Saez
Journal:  Mol Cell Endocrinol       Date:  2001-06-20       Impact factor: 4.102

Review 3.  Lutropin receptor function: insights from natural, engineered, and computer-simulated mutations.

Authors:  F Fanelli; A P Themmen; D Puett
Journal:  IUBMB Life       Date:  2001-03       Impact factor: 3.885

4.  Changes in Leydig cell gene expression during development in the mouse.

Authors:  P J O'Shaughnessy; L Willerton; P J Baker
Journal:  Biol Reprod       Date:  2002-04       Impact factor: 4.285

5.  Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene.

Authors:  Z M Lei; S Mishra; W Zou; B Xu; M Foltz; X Li; C V Rao
Journal:  Mol Endocrinol       Date:  2001-01

6.  MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR.

Authors:  Takashi Hirakawa; Colette Galet; Mario Ascoli
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

Review 7.  The lutropin/choriogonadotropin receptor, a 2002 perspective.

Authors:  Mario Ascoli; Francesca Fanelli; Deborah L Segaloff
Journal:  Endocr Rev       Date:  2002-04       Impact factor: 19.871

8.  Differential regulation of rat testicular 5alpha-reductase type 1 and 2 isoforms by testosterone and FSH.

Authors:  K Pratis; L O'Donnell; G T Ooi; P G Stanton; R I McLachlan; D M Robertson
Journal:  J Endocrinol       Date:  2003-03       Impact factor: 4.286

9.  Effects of insulin-like growth factor I on steroidogenic enzyme expression levels in mouse leydig cells.

Authors:  Gui-Min Wang; Peter J O'Shaughnessy; Curtis Chubb; Bernard Robaire; Matthew P Hardy
Journal:  Endocrinology       Date:  2003-08-07       Impact factor: 4.736

10.  Molecular characterization of postnatal development of testicular steroidogenesis in luteinizing hormone receptor knockout mice.

Authors:  Fu-Ping Zhang; Tomi Pakarainen; Fei Zhu; Matti Poutanen; Ilpo Huhtaniemi
Journal:  Endocrinology       Date:  2003-11-26       Impact factor: 4.736

View more
  6 in total

Review 1.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

2.  The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.

Authors:  Soichi Yamashita; Ping Tai; Jean Charron; CheMyong Ko; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2011-04-28

3.  The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.

Authors:  Maria Eugenia Matzkin; Soichi Yamashita; Mario Ascoli
Journal:  Mol Cell Endocrinol       Date:  2013-03-07       Impact factor: 4.102

Review 4.  Genetic Models for the Study of Luteinizing Hormone Receptor Function.

Authors:  Prema Narayan
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-29       Impact factor: 5.555

5.  Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis.

Authors:  Paul A Fowler; Siladitya Bhattacharya; Jörg Gromoll; Ana Monteiro; Peter J O'Shaughnessy
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

6.  Overexpression of PRL7D1 in Leydig Cells Causes Male Reproductive Dysfunction in Mice.

Authors:  Yaping Liu; Xingyu Su; Jie Hao; Maoxin Chen; Weijia Liu; Xiaogang Liao; Gang Li
Journal:  Int J Mol Sci       Date:  2016-01-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.